Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Pilot Study of Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination with Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk Neuroblastoma
Protocol ID
ANBL1921
Disease (Sub Disease)
Neuroblastoma
Diagnosis Stage
New Diagnosis
Location
WA
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Trial Status
Open
Sites
Perth Children's Hospital
Study Type
Treatment
Phase
Pilot
Age Eligibility
up to 30 Years
International registry ID's
NCT04385277
Back to Registry
Study Title Pilot Study of Dinutuximab Sargramostim (GM-CSF) and Isotretinoin in Combination with Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk Neuroblastoma
Protocol ID ANBL1921
Disease (Sub Disease) Neuroblastoma
Diagnosis Stage New Diagnosis
Location WA
Sponsor Children's Oncology Group
Collaborators National Cancer Institute (NCI)
Links https://clinicaltrials.gov/ct2/show/NCT04385277
Trial Status Open
Trial Open Date 30/11/2020
Sites Perth Children's Hospital
Study Type Treatment
Phase Pilot
Age Eligibility up to 30 Years
International registry ID's NCT04385277